95
Views
3
CrossRef citations to date
0
Altmetric
Hormone Therapy

Attitude of German women towards hormone therapy: results of a lay survey

, , , &
Pages 460-464 | Received 08 Nov 2012, Accepted 27 Nov 2012, Published online: 30 Jan 2013

References

  • Rossouw JE, Anderson GL, Prentice RL, et al. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–33
  • Tao M, Teng Y, Shao H, et al. Knowledge, perceptions and information about hormone therapy (HT) among menopausal women: a systematic review and meta-synthesis. PLoS One 2011;6:e24661
  • Hoffmann M, Hammar M, Kjellgren KI, et al. Changes in women’s attitudes towards and use of hormone replacement therapy after HERS and WHI. Maturitas 2005;52:11–17
  • Birkhäuser MH, Reinecke I. Current trends in hormone replacement therapy: perceptions and usage. Climacteric 2008;11:192–200
  • Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA 2004;291:1701–12
  • LaCroix AZ, Chlebowski RT, Manson JE, et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 2011;305:1305–14
  • Woodis CB. Hormone therapy for the management of menopausal symptoms: pharmacotherapy update. J Pharm Practice 2010;23:540–7
  • Eggertson L. New clinical guidelines say misconceptions have surrounded hormone therapy. CMAJ 2009;180:504–5
  • North American Menopause Society. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society. Menopause 2007;14:168–82
  • Hormontherapie in der Peri- und Postmenopause (HT). Available from: http://www.awmf.org/uploads/tx_szleitlinien/015-062_S3_Hormontherapie_in_der_Peri-_und_Postmenopause__HT__lang_09-2009_12-2011.pdf [last accessed 20 Feb 2012]
  • MRS – the menopause rating scale, developed by the Berlin Center for Epidemiology and Health research. Available from: http://www.menopause-rating-scale.info/about.htm [last accessed 30 Mar 2012]
  • Strothmann A, Schneider HPG. Hormone therapy: the European women’s perspective. Climacteric 2003;5:337–46
  • Du Y, Doren M, Melchert HU, et al. Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003. BMC Women’s Health 2007;7:19
  • Clanget C, Hinke V, Lange S, et al. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI. Exp Clin Endocrinol Diabetes 2005;113:529–33
  • Parsells Kelly J, Kaufmann DW, et al. Use of postmenopausal hormone therapy since the Women’s Health Initiative findings. Pharmacoepidemiol Drug Saf 2005;14:837–42
  • Buhling KJ, Studnitz FS, Jantke A, et al. Attitude of German gynecologists towards prescribing HRT before and after the WHI study. Climacteric 2012;15:326–31
  • Moen MH, Nilsen ST, Iversen OE. A significant change in Norwegian Gynecologist’s attitude to hormone therapy is observed after the results oft he Womens Health Initivative study. Acta Obstet Gynecol Scand 2005;84:92–3
  • Ettinger B, Grady D, Tosteson AN, et al. Effect oft he Women’s Health Initative on women’s deicision to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003;102:1225–32
  • Usher C, Teeling M, Bennet K, Feely J. Effect of clinical trial publicity on HRT prescribing in Ireland. Eur J Clin Pharmacol 2006;62:307–10
  • MacLennan AH, Taylor AW, Wilson DH. Hormone therapy use after the Women’s Health Initiative. Climacteric 2004;7:138–42
  • Waaseth M, Bakken K, Lund E. Patterns of hormone therapy use in the Norwegian women and cancer study (NOWAC) 1996–2005. Maturitas 2009;63:220–6
  • Du Y, Scheidt-Nave C, Schaffrath Rosario A, et al. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study. Climacteric 2009;12:329–40
  • Lawton B, Rose S, McLeod D, Dowell A. Changes in the use of hormone replacement therapy after the report from the Women’s Health Initiative: cross sectional survey of users. BMJ 2003;327:845–6
  • Huang WF, Tsai YW, Hsiao FY, Liu WC. Change of the prescription of hormone therapy in menopausal women: an observational study in Taiwan. BMC Public Health 2007;17:7–56
  • Heineman LAJ, DoMinh T, Strelow F, et al. The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health Qual. Life Outcomes 2004;2:67
  • Chuni N, Sreeramareddy CT. Frequency of symptoms, determinants of severe symptoms, validity of and cut-off score for Menopause Rating Scale (MRS) as a screening tool: a cross-sectional survey among midlife Nepalese women. BMC Womens Health 2011;11:30
  • Genazzani AR, Schneider HPG, Panay M, Nijland EA. The European Menopause Survey 2005: Women’s perceptions on the menopause and postmenopausal hormone therapy. Gynecolical Endocrinol 2006;22:369–75
  • Uncu Y, Alper Z, Ozdemir H, et al. The perception of menopause and hormone therapy among women in Turkey. Climacteric 2007;10:63–71
  • Paine BJ, Stocks NP, Ramsay EN, et al. Use and perception of hormone therapy following media reports of the Women’s Health Initiative: a survey of Australian WISDOM participants. Climacteric 2004;7:143–52
  • Stadberg E, Mattsson L, Milsom I. Womens attitudes and knowledge about the climacteric period and its treatment: a Swedish population-based study. Maturitas 1997;27:109–16

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.